SenzaGen AB (OSTO:SENZA) Change In Payables And Accrued Expense : kr0.00 Mil (TTM As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is SenzaGen AB Change In Payables And Accrued Expense?

SenzaGen AB's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2025 was kr0.00 Mil. It means SenzaGen AB's Accounts Payable & Accrued Expense stayed the same from Dec. 2024 to Mar. 2025 .

SenzaGen AB's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2024 was kr0.00 Mil. It means SenzaGen AB's Accounts Payable & Accrued Expense stayed the same from Dec. 2023 to Dec. 2024 .

SenzaGen AB Change In Payables And Accrued Expense Historical Data

The historical data trend for SenzaGen AB's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SenzaGen AB Change In Payables And Accrued Expense Chart

SenzaGen AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

SenzaGen AB Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

SenzaGen AB Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

SenzaGen AB Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of SenzaGen AB's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

SenzaGen AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SenzaGen AB (OSTO:SENZA) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Scheeletorget 1, Medicon Village, Building 401, Lund, SWE, 223 81

Website

https://www.senzagen.com

SenzaGen AB markets sells, and performs the in vitro Genomic Allergen Rapid Detection (GARD) sensitization test through its laboratory and licensed Contract Research Organizations (CROs) in Sweden. It offers animal-free testing of chemical compounds in cosmetics, pharmaceuticals, food products, and dyes. It operates in five market segments- Cosmetics, Chemicals, Medical devices, Pharmaceuticals, and Nutrition/food additives. The majority is from the Pharmaceuticals segment. Geographically it operates in North America, Europe, APAC, and RoW, the majority is from Europe.

SenzaGen AB Headlines

No Headlines